🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 75383L102
- IPO
- 6/7/2024 · $17.00/share
Business: Rapport Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders.
Company Contact
- CEO
- Abraham N. Ceesay
- CFO
- Troy Ignelzi
- Headquarters
- 1325 Boylston Street, Suite 401, Boston, MA 02215
- Phone
- 857-321-8020